🇺🇸 FDA
Pipeline program

CORT125329 lipid capsule formulation

CORT125329-140

Phase 1 small_molecule completed

Quick answer

CORT125329 lipid capsule formulation for Healthy is a Phase 1 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CORCEPT THERAPEUTICS INC
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials